DURBAN, South Africa — Doctors and nurses at a South African hospital group noticed an odd spike in the number of Covid-19 patients in their wards in late October. The government had slackened its lockdown grip, and springtime had brought more parties. But the numbers were growing too quickly to easily explain, prompting a distressing question.
“Is this a different strain?” one hospital official asked in a group email in early November, raising the possibility that the virus had developed a dangerous mutation.
With no robust system to identify genetic variations of the coronavirus, experts warn that the United States is woefully ill-equipped to track a dangerous new mutant, leaving health officials blind as they try to combat the grave threat.
The variant, which is now surging in Britain and burdening its hospitals with new cases, is rare for now in the United States. But it has the potential to explode in the next few weeks, putting new pressures on American hospitals, some of which are already near the breaking point.
In March, Marc Price set up a tent outside his primary care practice in Malta, N.Y., where he and his colleagues could don their protective gear to see the daily stream of coronavirus patients. Three weeks ago, the tent was finally upgraded to a shed ahead of snowstorms. But, despite months of constant close contact with Covid-19 patients, staff at the practice have yet to be vaccinated.
The coronavirus variant that was first spotted last month in the U.K. has now spread to dozens of countries, likely passed on by infected people who traveled around the world and unknowingly brought the microscopic invaders with them.
Recent Comments